J Korean Surg Soc.  2012 Mar;82(3):165-171. 10.4174/jkss.2012.82.3.165.

Risk factors of circumferential resection margin involvement in the patients with extraperitoneal rectal cancer

• Oh SJ
• Shin JY

• KMID: 2212218
• DOI: http://doi.org/10.4174/jkss.2012.82.3.165

Abstract

PURPOSE
Currently, circumferential resection margins (CRM) are used as a clinical endpoint in studies on the prognosis of rectal cancer. Although the concept of a circumferential resection margin in extraperitoneal rectal cancer differs from that in intraperitoneal rectal cancer due to differences in anatomical and biologic behaviors, previous reports have provided information on CRM involvement in all types of rectal cancer including intraperitoneal lesions. Therefore, the aim of this study was to analyze risk factors of CRM involvement in extraperitoneal rectal cancer.
METHODS
From January 2005 to December 2008, 306 patients with extraperitoneal rectal cancer were enrolled in a prospectively collected database. Multivariate logistic regression analysis was used to identify predictors of CRM involvement.
RESULTS
The overall rate of CRM involvement was found to be 16.0%. Multivariate analysis showed that male sex, larger tumor size (> or =4 cm), stage higher than T3, nodal metastasis, tumor perforation and non-sphincter preserving proctectomy (NSPP) were risk factors for CRM involvement.
CONCLUSION
Male sex, larger tumor size (> or =4 cm), advanced T stage, nodal metastasis, tumor perforation, and NSPP are significant risk factors of CRM involvement in extraperitoneal rectal cancer. Given that postoperative chemoradiotherapy is recommended for patients with a positive CRM, further oncologic studies are warranted to ascertain which patients with these risk factors would require adjuvant therapy.

Keyword

Circumferential resection margin; Rectal neoplasms; Risk factors

MeSH Terms

Chemoradiotherapy
Humans
Logistic Models
Male
Multivariate Analysis
Neoplasm Metastasis
Prognosis
Prospective Studies
Rectal Neoplasms
Risk Factors

Reference

1. Nagtegaal ID, Marijnen CA, Kranenbarg EK, van de Velde CJ, van Krieken JH, et al. Pathology Review Committee. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol. 2002. 26:350–357.

2. Tekkis PP, Heriot AG, Smith J, Thompson MR, Finan P, Stamatakis JD, et al. Comparison of circumferential margin involvement between restorative and nonrestorative resections for rectal cancer. Colorectal Dis. 2005. 7:369–374.

3. Sebag-Montefiore D, Stephens RJ, Steele R, Monson J, Grieve R, Khanna S, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009. 373:811–820.

4. Nagtegaal ID, Quirke P. What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol. 2008. 26:303–312.

5. den Dulk M, Collette L, van de Velde CJ, Marijnen CA, Calais G, Mineur L, et al. Quality of surgery in T3-4 rectal cancer: involvement of circumferential resection margin not influenced by preoperative treatment. Results from EORTC trial 22921. Eur J Cancer. 2007. 43:1821–1828.

6. Chapuis PH, Lin BP, Chan C, Dent OF, Bokey EL. Risk factors for tumour present in a circumferential line of resection after excision of rectal cancer. Br J Surg. 2006. 93:860–865.

7. Birbeck KF, Macklin CP, Tiffin NJ, Parsons W, Dixon MF, Mapstone NP, et al. Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg. 2002. 235:449–457.

8. Gosens MJ, van Krieken JH, Marijnen CA, Meershoek-Klein Kranenbarg E, Putter H, Rutten HJ, et al. Improvement of staging by combining tumor and treatment parameters: the value for prognostication in rectal cancer. Clin Gastroenterol Hepatol. 2007. 5:997–1003.

9. Faerden AE, Naimy N, Wiik P, Reiertsen O, Weyessa S, Trønnes S, et al. Total mesorectal excision for rectal cancer: difference in outcome for low and high rectal cancer. Dis Colon Rectum. 2005. 48:2224–2231.

10. Lopez-Kostner F, Lavery IC, Hool GR, Rybicki LA, Fazio VW. Total mesorectal excision is not necessary for cancers of the upper rectum. Surgery. 1998. 124:612–617.

11. Wibe A, Syse A, Andersen E, Tretli S, Myrvold HE, Søreide O, et al. Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection. Dis Colon Rectum. 2004. 47:48–58.

12. Bernstein TE, Endreseth BH, Romundstad P, Wibe A. Norwegian Colorectal Cancer Group. Circumferential resection margin as a prognostic factor in rectal cancer. Br J Surg. 2009. 96:1348–1357.

13. Wang C, Zhou ZG, Yu YY, Shu Y, Li Y, Yang L, et al. Occurrence and prognostic value of circumferential resection margin involvement for patients with rectal cancer. Int J Colorectal Dis. 2009. 24:385–390.

14. Quirke P, Dixon MF. The prediction of local recurrence in rectal adenocarcinoma by histopathological examination. Int J Colorectal Dis. 1988. 3:127–131.

15. Sobin LH. TNM, sixth edition: new developments in general concepts and rules. Semin Surg Oncol. 2003. 21:19–22.

16. Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet. 1986. 2:996–999.

17. Wibe A, Rendedal PR, Svensson E, Norstein J, Eide TJ, Myrvold HE, et al. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg. 2002. 89:327–334.

18. Benzoni E, Terrosu G, Bresadola V, Cerato F, Cojutti A, Milan E, et al. Analysis of clinical outcomes and prognostic factors of neoadjuvant chemoradiotherapy combined with surgery: intraperitoneal versus extraperitoneal rectal cancer. Eur J Cancer Care (Engl). 2006. 15:286–292.

19. Eriksen MT, Wibe A, Hestvik UE, Haffner J, Wiig JN, et al. Norwegian Rectal Cancer Group. Surgical treatment of primary locally advanced rectal cancer in Norway. Eur J Surg Oncol. 2006. 32:174–180.

20. Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, Smith AM, et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet. 2005. 365:1718–1726.

21. Zhou ZG, Hu M, Li Y, Lei WZ, Yu YY, Cheng Z, et al. Laparoscopic versus open total mesorectal excision with anal sphincter preservation for low rectal cancer. Surg Endosc. 2004. 18:1211–1215.